Ascendant Capital Management’s CME Group CME Stock Holding History

Ascendant Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$958K	Buy	+5,000	New	+$904K	1.26%	30

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Ascendant Capital Management's CME Position: Q1 2023 in Review

Ascendant Capital Management opened a new position in CME Group (CME) in Q1 2023: 5,000 shares worth $958K. The stake represents 1.26% of the portfolio and ranks #30 among its holdings.

1,171 funds tracked by Wall St. Rank hold CME as of Q1 2023.

Ascendant Capital Management held 5,000 shares of CME Group worth $958K as of Q1 2023.
CME Group was a new Ascendant Capital Management position in Q1 2023.
CME Group made up 1.26% of Ascendant Capital Management's portfolio in Q1 2023, its #30 holding.
1,171 funds tracked by Wall St. Rank held CME Group as of Q1 2023.

Based on Ascendant Capital Management's 13F filing for Q1 2023, filed 15 May 2023.